Chinese porcine joint venture received regulatory approval, triggering final $7.5M milestone payment from BCA to Genus.

British animal genetics company Genus expects to report full-year adjusted pretax profit "moderately above" the upper end of current market expectations, sending its shares as much as 15.3% higher on ...

Last September, Basingstoke-based Genus struck a deal to accelerate its 49%-owned porcine joint venture with BCA in China.

Following this strong performance, Genus now anticipates its full-year 2026 adjusted profit before tax to be moderately above the top end of current market expectations, which range from £82.7 million ...

Genus PLC (GENSF) achieved strong financial results with a 30% increase in group adjusted operating profit in constant currency. The company reported a significant milestone with the US FDA approval ...